Provided by Tiger Fintech (Singapore) Pte. Ltd.

Corbus Pharmaceuticals

6.79
+0.37005.76%
Post-market: 6.790.00000.00%18:49 EDT
Volume:136.00K
Turnover:921.26K
Market Cap:83.06M
PE:-1.84
High:6.90
Open:6.51
Low:6.47
Close:6.42
Loading ...

U.S. RESEARCH ROUNDUP-Autodesk, Coca-Cola, NetApp

Reuters
·
28 Feb

Corbus Pharmaceuticals Holdings Inc : William Blair Initiates Coverage With Outperform Rating

THOMSON REUTERS
·
28 Feb

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
28 Feb

Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire
·
25 Feb

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
25 Feb

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
22 Feb

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
19 Feb

Analysts Offer Insights on Healthcare Companies: Cybin (CYBN) and Corbus Pharmaceuticals (CRBP)

TIPRANKS
·
18 Feb

Promising Potential of Corbus Pharmaceuticals’ CRB-701 in Oncology: A Strong Buy Rating by Andrew Fein

TIPRANKS
·
18 Feb

Corbus Pharmaceuticals Price Target Maintained With a $75.00/Share by HC Wainwright & Co.

Dow Jones
·
18 Feb

Mizuho Securities Reaffirms Their Buy Rating on Corbus Pharmaceuticals (CRBP)

TIPRANKS
·
17 Feb

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
15 Feb

Corbus Pharmaceuticals Reports Positive Data From Cancer Drug Trial -- Shares Slump

MT Newswires Live
·
15 Feb

Corbus Pharmaceuticals Reports Promising Phase 1 Trial Results

TIPRANKS
·
14 Feb

Corbus Pharmaceuticals Holdings Inc. Stock Rallies 5.1%, Outperforms Competitors

Dow Jones
·
14 Feb

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
12 Feb